North Hollywood, CA, June 17, 2014 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – applauds Gov. John Kasich of Ohio for signing SB 99, The Cancer Treatment Modernization Act, into law. The bill requires that health plans regulated by the state that provide coverage for IV and oral anticancer treatments not exceed $100 copayment or coinsurance for a 30-day supply of orally administered anticancer treatment.
“It’s encouraging to see states recognize that policy needs to keep pace with medical advances that offer lifelines to patients who have exhausted other treatments,” said Susie Novis, President and Co-Founder of the IMF. “On behalf of cancer patients, the IMF is passionately engaged in raising awareness of this discrepancy in health care coverage in legislatures across the nation. We are grateful to Ohio State Sen. Scott Oelslager (R-North Canton) for his swift action and commitment to passing this bill this year. He is a true champion of the cancer community.”
“After years of high out-of-pocket expenses and an inability to afford the most effective therapies, cancer patients in Ohio will finally have access to life-saving, cutting-edge oral anticancer medications,” said Zina Cary, National State Affairs Consultant for the IMF.
“I am happy to be celebrating the passage of SB 99 in Ohio,” said Nick Menedis, advocate and IMF Support Group Leader in Columbus, Ohio. “I have been blessed with good health insurance coverage for my oral chemotherapy treatment since I was diagnosed; however, many patients in my support group have not been so fortunate. SB 99 places all cancer patients in Ohio on the same level for treatment. Now we need to turn our focus towards HR 1801 at the federal level so that cancer patients across the USA might enjoy the same benefits.”
Ohio joins 33 other states and the District of Columbia in passing similar legislation. Visit http://speac.myeloma.org for the map and full list of states.
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
Celebrating its 23rd anniversary, the International Myeloma Foundation reaches more than 350,000 members in 120 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses on four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned hotline, and established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter at @IMFmyeloma.
National State Affairs Consultant